To deal with Grown ups with relapsed or refractory multiple myeloma who've received at the very least four prior therapies To scale back proteinuria in Older people with primary immunoglobulin A nephropathy vulnerable to rapid disorder progression Because the enactment of PDUFA in 1992, the standard amount of approvals https://juliuss470ria5.wikipresses.com/user